GlassScriptPhysician profile
Jonathan C Welch
NPI 1407024227
$3,211.90
in general payments reported to CMS, 2019-2025
25 companies · $548 in 2025
The $548 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $200 · 2020: $184 · 2021: $560 · 2022: $438 · 2023: $618 · 2024: $663 · 2025: $548.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,804 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,803.88 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $786.00 | 2022-2025 | Durysta, Lumigan, Alphagan P |
| Johnson & Johnson Surgical Vision, INC. | $469.89 | 2019-2023 | Tecnis Iol, Tecnis Iol, One Series Ultra |
| Biotissue Holdings INC. | $392.97 | 2022-2025 | |
| Allergan, INC. | $362.09 | 2019-2022 | |
| Rxsight INC | $248.35 | 2021-2025 | Rxsight Injector Handpiece, Rxsight Injector Cartridge, Rxsight Contact Lens |
| Alcon Vision LLC | $232.93 | 2019-2025 | Tryptyr, Clareon, Rocklatan |
| Oyster Point Pharma, INC. | $108.38 | 2023-2025 | Tyrvaya, Ryzumvi |
| Amgen INC. | $84.14 | 2024-2025 | Tepezza |
| Novartis Pharmaceuticals Corporation | $79.09 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $71.84 | 2023-2024 | Miebo, Vyzulta |
| Ocular Therapeutix, INC. | $53.11 | 2021 | |
| Harrow Eye, LLC | $47.99 | 2025 | Vevye |
| Tarsus Pharmaceuticals, INC. | $47.73 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $36.30 | 2022 | |
| Kala Pharmaceuticals, INC. | $24.60 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $23.59 | 2023 | Inspire |
| Rayner Intraocular Lenses Limited | $22.90 | 2023 | Omidria, Rayone Spheric, Rayone Emv |
| Omeros Corporation | $19.74 | 2019 | |
| Mallinckrodt Hospital Products INC. | $18.84 | 2022 | |
| Thea Pharma INC. | $17.45 | 2024 | Iyuzeh |
| Eyevance Pharmaceuticals LLC | $14.72 | 2022 | |
| Dompe US, INC. | $13.25 | 2024 | Oxervate |
| Horizon Therapeutics Plc | $12.55 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $11.77 | 2021 | |
| Aerie Pharmaceuticals, INC. | $11.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Welch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.